NHS Fights To Revive £220M Drug Patent Suit At Top UK Court
The National Health Service argued at the U.K.'s highest court on Wednesday that its £220 million ($300 million) lawsuit accusing pharmaceutical giant Servier of dishonestly securing a patent for a blood...To view the full article, register now.
Already a subscriber? Click here to view full article